This brand name is authorized in Japan, Turkey
The drug CEFAMEZIN contains one active pharmaceutical ingredient (API):
|
1
Cefazolin
UNII IHS69L0Y4T - CEFAZOLIN
|
|
Cefazolin is a bactericidal cephalosporin antibiotic of the first generation for parenteral administration. Cephalosporins inhibit cell wall synthesis (in the growth stage) through blocking the penicillin-binding proteins (PBPs) like transpeptidases. The outcome is a bactericidal action. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J01DB04 | Cefazolin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DB First-generation cephalosporins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 6132401D1045, 6132401D2084, 6132401D3145, 6132401D4141, 6132401E1040, 6132401E2063, 6132401G1041, 6132401G3052 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699502270107, 8699502270206, 8699502270787 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
